Difference between revisions of "Su J, et al. Mol. Carcinogen. (2016) cited as Ref 175 in DOI: 10.1038/s41392-020-0110-5 (Q9438)"
Jump to navigation
Jump to search
(Created claim: Page(s) (P105): 1962-1973, #quickstatements; #temporary_batch_1590074839150) |
(Created claim: Fourth Author string (P152): Li L, #quickstatements; #temporary_batch_1590155310798) |
||
| Property / Fourth Author string | |||
| + | Li L | ||
| Property / Fourth Author string: Li L / rank | |||
| + | Normal rank | ||
Revision as of 13:49, 22 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Su J, et al. Mol. Carcinogen. (2016) cited as Ref 175 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Su J
0 references
Wu S
0 references
Wu H
0 references
2016
0 references
Mol. Carcinogen.
0 references
55
0 references
CD44 is functionally crucial for driving lung cancer stem cells metastasis through Wnt/beta-catenin-FoxM1-Twist signaling (English)
0 references
1962-1973
0 references
Li L
0 references
